IRIS

4.2 Abstract in Atti di convegno: [696] Home page tipologia

Sfoglia
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 21 a 40 di 696
Titolo Data di pubblicazione Autore(i) File
miRNA landscape analysis of stage I EOC, identifies miR-199a-5p associated to poor prognosis in grade 3 subgroup 1-gen-2013 Calura, E; Fruscio, R; Paracchini, L; Bignotti, E; Martini, P; Ravaggi, A; Di Marino, M; Sales, G; Beltrame, L; Dell'Orto, F; Baldo, R; Pecorelli, S; Sartori, E; Zanotti, L; Katsaros, D; Tognon, G; D'Incalci, M; Romualdi, C; Marchini, S
EPOC-experiences - conducting a multinational clinical trial on the pharmacology of doxorubicin in children with cancer 1-gen-2013 Krischke, M; Andre, N; Boddy, A; Bode, G; D'Incalci, M; Hempel, G; Kontny, N; Steel, A; Voller, V; Boos, J
Pharmacokinetics of concomitant cisplatin and paclitaxel administration by hyperthermic intraperitoneal chemotherapy (HIPEC) to patients with peritoneal carcinomatosis 1-gen-2013 Ansaloni, L; Busci, Lm; Coccolini, F; Grosso, G; Lotti, M; Morosi, L; Poiasina, E; Zucchetti, M; D'Incalci, M; Frigerio, L
RANDOMIZED, NON-COMPARATIVE, PHASE II TRIAL OF BEVACIZUMAB AND TRABECTEDIN WITH OR WITHOUT CARBOPLATIN IN PARTIALLY PLATINUM-SENSITIVE OVARIAN CANCER (ROC) WOMEN 1-gen-2017 Colombo, N; Nicoletto, Mo; Lissoni, A; Scambia, G; Tognon, G; Negri, E; Galli, F; Biagioli, E; Rulli, E; Fossati, R; D'Incalci, M
AN OPEN-LABEL, RANDOMIZED PHASE II STUDY ON TRABECTEDIN AND BEVACIZUMAB WITH OR WITHOUT CARBOPLATIN IN PARTIALLY PLATINUM-SENSITIVE (PPS) OVARIAN CANCER 1-gen-2014 Gerardi, C; Floriani, I; Biagioli, E; D'Incalci, M; Fossati, R; Colombo, N
Fsn0503h antibody-mediated blockade of cathepsin S as potential therapeutic strategy for the treatment of solid tumors 1-gen-2013 Vazquez, R; Astorgues-Xerri, L; Cvitkovic, E; Bekradda, M; Fleck, R; Gormley, J; Buick, R; Kerr, P; Raymond, E; D'Incalci, M; Frapolli, R; Riveiro, Me
A dose dense schedule improves antitumor activity of trabectedin in myxoid liposarcoma with type III FUS-CHOP chimera 1-gen-2014 Uboldi, S; Frapolli, R; Bello, E; Brich, S; Bozzi, F; Sanfilippo, R; Casali, Pg; Gronchi, A; Galmarini, Cm; Sousa-Faro, Jmf; Pilotti, S; D'Incalci, M
MIRNA181A-5P EXPRESSION AS A BIOMARKER OF TGFB PATHWAY ACTIVATION ASSOCIATED WITH ONCOLOGIC OUTCOME AND TUMOR DIFFUSION IN HIGH GRADE SEROUS EPITHELIAL OVARIAN CANCER 1-gen-2017 Ceppi, L; Palazzi, S; Romualdi, C; Dilorenzo, P; Grassi, T; Biagioli, E; Paracchini, L; Milani, R; Buda, A; D'Incalci, M; Marchini, S; Fruscio, R
In silico rendering of cell cycle progression of erlotinib and gemcitabine treatment in pancreatic cancer cells 1-gen-2015 Lupi, M; Falcetta, F; D'Incalci, M; Ubezio, P
Pharmacokinetic study of trabectedin administered as 24-hour infusion in elderly patients with advanced soft tissue sarcoma (STS) treated according to the TR1US ISG study 1-gen-2016 Ferrari, M; Grosso, F; Grignani, G; Ibrahim, T; Tamberi, S; Marra, D; Marchesi, E; Porcu, L; D'Incalci, M; Zucchetti, M
MIRNA LANDSCAPE IN STAGE I EPITHELIAL OVARIAN CANCER DEFINES THE HISTOTYPE SPECIFICITIES 1-gen-2013 Bignotti, E; Calura, E; Fruscio, R; Paracchini, L; Ravaggi, A; Zanotti, L; Tognon, G; D'Incalci, M; Sartori, E; Pecorelli, S
MICRORNA PROFILE IN BONE MARROW FIBROBLASTS FROM PATIENTS WITH MULTIPLE MYELOMA 1-gen-2015 Desantis, V; Caparrotta, I; Beltrame, L; Di Marzo, L; Marchini, S; Catacchio, I; D'Incalci, M; Vacca, A; Frassanito, Ma
DIAGNOSTIC AND PROGNOSTIC IMPACT OF MICRORNA EXPRESSION IN SERUM OF HIGH-GRADE SEROUS OVARIAN CARCINOMA PATIENTS 1-gen-2015 Bignotti, E; Todeschini, P; Ravaggi, A; Ferracin, M; Sartori, E; Odicino, F; Tognon, G; Negrini, M; D'Incalci, M; Marchini, S; Romualdi, C
Pharmacokinetics of the Novel FGFR and VEGFR Inhibitor, E-3810, in Patients with Advanced Solid Tumors Participating to a Phase I/II Trial 1-gen-2012 Zangarini, M; Sala, F; Camboni, Mg; Cereda, R; Livi, V; Bahleda, R; Dienstmann, R; Delmonte, A; D'Incalci, M; Zucchetti, M
OTX015 effects in triple-negative breast cancer (TNBC) models are independent of hypoxia conditions and synergistic with other anticancer agents 1-gen-2015 Vazquez, R; Astorgues-Xerri, L; Riveiro, Me; Beltrame, L; Marchini, S; Bertoni, F; Kwee, I; Mohamed, M; Cvitkovic, E; Frapolli, R; D'Incalci, M
CIRCULATING MIRNA LANDSCAPE IDENTIFIES MIR-1246 AS PROMISING DIAGNOSTIC BIOMARKER IN HIGH-GRADE SEROUS OVARIAN CARCINOMA: A VALIDATION ACROSS TWO INDEPENDENT COHORTS 1-gen-2017 Bignotti, E; Todeschini, P; Salviato, E; Paracchini, L; Ferracin, M; Petrillo, M; Zanotti, L; Tognon, G; Gambino, A; Calura, E; Beltrame, L; Odicino, F; Sartori, E; Scambia, G; Negrini, M; Ravaggi, A; D'Incalci, M; Marchini, S; Romualdi, C
Activation of TGF-Beta Pathway Through Mir-181a and Psmad-2 Overexpression Drives Resistance To Neoadjuvant Chemotherapy in High Grade Serous Advanced Ovarian Cancer 1-gen-2015 Petrillo, M; Marchini, S; Romualdi, C; Beltrame, L; Martinelli, E; Difeo, A; D'Incalci, M; Zannoni, Gf; Scambia, G
Insulin-like growth factor binding protein-4 (IGFBP-4) tumor and serum levels are increased across all stages of epithelial ovarian cancer 1-gen-2012 Mosig, R; Lobl, M; Cohen, S; Chudin, E; Fruscio, R; Marchini, S; D'Incalci, M; Sachidanandam, R; Dottino, P; Martignetti, J
OTX015, a novel pan BET-BRD inhibitor is active in non-small-cell lung cancer (NSCLC) cell lines bearing the fusion protein EML4-ALK 1-gen-2014 Vazquez, R; Astorgues-Xerri, L; Bekradda, M; Cvitkovic, E; Herait, P; Boi, M; Inghirami, G; D'Incalci, M; Riveiro, Me; Raymond, E
PM01183 shows an improved therapeutic index relative to trabectedin and suppresses EWS/FLI1 activity at clinically achievable concentrations 1-gen-2014 Harlow, M; Maloney, N; Navarro, Mjg; D'Incalci, M; Galmarini, C; Marin, Pma; Grohar, P
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 21 a 40 di 696
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile

Scopri
Tipologia
  • 4 Contributo in Atti di Convegno ...696
Autore
  • Marcacci, Maurilio180
  • S. Zaffagnini96
  • CIVILINI, EFREM74
  • Chiesa R64
  • KON, ELIZAVETA61
  • VINCIGUERRA, PAOLO58
  • ASSELTA, ROSANNA54
  • DUGA, STEFANO51
  • Melissano G50
  • Tenchini ML39
Data di pubblicazione
  • 2010 - 2020351
  • 2000 - 2009284
  • 1990 - 199950
  • 1980 - 198911
Editore
  • s.n109
  • sn21
  • Springer4
  • AMER SOC CLINICAL ONCOLOGY, 2318 ...3
  • IMECHE2
  • ISAKOS2
  • Oxford University Press2
  • s.n.2
  • Societá Italiana di Ortopedia e T...2
  • 5th Biennal ISAKOS Congress1
Rivista
  • ANNALS OF ONCOLOGY23
  • JOURNAL OF CLINICAL ONCOLOGY21
  • GASTROENTEROLOGY20
  • EUROPEAN JOURNAL OF CANCER13
  • JOURNAL OF CROHN'S AND COLITIS10
  • KNEE SURGERY, SPORTS TRAUMATOLOGY...10
  • NEURO-ONCOLOGY10
  • INTERNATIONAL JOURNAL OF GYNECOLO...7
  • CANCER RESEARCH6
  • ITALIAN JOURNAL OF VASCULAR AND E...6
Keyword
  • .23
  • acl reconstruction3
  • autologous chondrocyte transplant...2
  • Cartilage Repair2
  • Lateral Collagen Meniscus Implant2
  • laxities2
  • Medial Collagen Meniscus Implant2
  • menisco2
  • Nano-Composite Biomaterial2
  • navigation system2
Lingua
  • eng347
  • ita116
  • fre7
  • und3
Accesso al fulltext
  • no fulltext669
  • reserved27